Industry Recognizes Algorithme Pharma as Preeminent CRO that Surpasses Sponsor Expectations and Provides Greater Value
(Laval, Quebec, Canada, March 20, 2014) – Algorithme Pharma, a full service early stage clinical research organization, has been presented with the Innovation, Productivity, Quality and Regulatory CRO Leadership Awards by Life Science Leader Magazine.
The annual competition winners are based on the responses of over 10,000 pharmaceutical and biopharmaceutical executives responsible for making or influencing outsourcing decisions. Algorithme Pharma was identified for being a research provider where innovation is reflected by continuous efforts to enhance in-house capabilities, where agreed upon objectives are consistently met to surpass sponsor expectations, where projects are treated as if they were their own, and where trials are conducted in a reliable and compliant manner.
“Partnering with our clients to get their drug through this critical early stage of drug development is our company focus. It is very rewarding to have these efforts recognized, as we work hard to treat every project with individualized attention and to provide a personalized and customized service that surpasses our clients’ expectations. Our company is continuously looking for ways to improve our customer relationships and range of services to create even greater value for our sponsors” stated Chris Perkin, Chief Executive Officer.
About Algorithme Pharma
Algorithme Pharma, an Altasciences Company, is a full service provider focused on early stage clinical research. With over 20 years’ experience, Algorithme Pharma successfully completes more than 200 clinical trials annually. Support services include large and small molecule Bioanalysis, Data Management, Biostatistics, Regulatory Support, Clinical Pharmacology and Project Management.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.